Hi Wasa, my reference to Cassava was to show that
a small bit of positive early stage small sample low scientific threshold AD results in the States
caused a tremendous gain in SP, got major NIH funding,
and is now a darling of independent investors.
If ACW’s more positive AD results and years of study and high potential impact across many dysfunctions were fully valued in the marketplace, I would be happier and there is no reason why ACW cannot be similarly aggressive and successful.
Ann: Resignation of Dr Bill Ketelbey as Chief Executive Officer, page-40
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $206.0M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 24515 | 8.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.0¢ | 82424 | 1 |
View Market Depth
| Last trade - 16.16pm 09/08/2024 (20 minute delay) ? |
| ACW (ASX) Chart |
Day chart unavailable